Duterte vows PH 'back to normal' by December, expects virus vaccine from China | Inquirer News

Duterte vows PH ‘back to normal’ by December, expects virus vaccine from China

By: - Reporter / @KAguilarINQ
/ 10:25 AM July 31, 2020

MANILA, Philippines — Life will be “back to normal” by December, President Rodrigo Duterte assured as he urged the public to wait a bit more for a vaccine to be developed against the coronavirus disease (COVID-19).

“I promise you, by the grace of God, I hope by December, we would be back to normal,” Duterte said in a taped address aired Friday.

Article continues after this advertisement

“Meron akong bakuna. Ang hingin ko sa inyo ganito, magtiis lang kayo ng konti dahil nga sa hawaan,” he added.

Duterte added that the country might get its first COVID-19 vaccine from China, even citing its promise to prioritize the Philippines.

“Kaya bilib din talaga ako sa mga Chinese eh, baka ang una nating makuha from China,” Duterte said.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: China, COVID-19, COVID-19 Vaccine, Rodrigo Duterte

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.